BPG is committed to discovery and dissemination of knowledge
Editorial Board
Dr. Guoxiang Xie is the vice president of the Human Metabolomics Institute (Guangdong, China) and an adjunct professor at Kunming University of Science and Technology, China. Dr. Xie received his M.D. degree in Pharmaceuticals from Shanghai Jiao Tong University, Shanghai, China. Previously, he has been an Assistant Professor of the University of Hawaii Cancer Center (a National Cancer Institute designated cancer center) (2013-2018). Dr. Xie also served as a research scientist in the Center for Translational Biomedical Research at the University of North Carolina at Greensboro for about 5 years. He was the first to establish a standardized metabolite assay kit in the field of metabolomics and now the kit has been commercialized and used in many international metabolomics laboratories. Dr. Xie also successfully develop a series of in vitro diagnostic (IVD) kits and tests which have received the approval from the National Medical Products Administration of China for disease diagnosis and management. He has worked on dozens of metabolomics projects that span the translational research spectrum from various rodent models to human clinical trials. Dr. Xie has published over 150 peer-reviewed papers on metabolomics and biomedical research, with over 14000 citations and an H-Index of 61. Dr. Xie is the associate editor of Frontiers in Pharmacology - Experimental Pharmacology and Frontiers in Pharmacology - Drug Discovery and Translational Pharmacology. He is also an editorial board member of BMC medicine. As a reviewer, Dr. Xie have reviewed more than 50 manuscripts for 30 journals including Nature Medicine, Nature Communications, Journal of Proteome Research, BMC medicine, etc.. Dr. Xie’s current research focuses on conducting comprehensive metabolomic studies to (1) identify the metabolite markers for disease diagnosis and stratification and (2) define the molecular mechanisms that link metabolic disruptions in gut microbial-host co-metabolism to metabolic disorders and gastrointestinal cancer. Dr. Xie has more than 20 years of experience as a scientist in bioanalytical science, metabolomics and in the medical field. Reading, travel, listening music.